# Michael S. Conte

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-s-conte/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,152 |
| Field | Peripheral Artery Disease Management |
| h-index | 76 |
| i10-index | 256 |
| Last Known Institution | University of California, San Francisco |
| OpenAlex ID | https://openalex.org/A5016520112 |
| ORCID iD | 0000-0001-9119-192X |
| Works | 598 |

## Researcher papers

Showing 12 of 13.

- [Global vascular guidelines on the management of chronic limb-threatening ischemia](https://scholariq.org/papers/global-vascular-guidelines-on-the-management-of-chronic-limb-threatening/)
- [The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI)](https://scholariq.org/papers/the-society-for-vascular-surgery-lower-extremity-threatened-limb-classification/)
- [Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia](https://scholariq.org/papers/global-vascular-guidelines-on-the-management-of-chronic-limb-threatening-2/)
- [Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer](https://scholariq.org/papers/five-year-mortality-and-direct-costs-of-care-for-people-with-diabetic-foot/)
- [Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication](https://scholariq.org/papers/society-for-vascular-surgery-practice-guidelines-for-atherosclerotic-occlusive/)
- [Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia](https://scholariq.org/papers/surgery-or-endovascular-therapy-for-chronic-limb-threatening-ischemia/)
- [Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery](https://scholariq.org/papers/results-of-prevent-iii-a-multicenter-randomized-trial-of-edifoligide-for-the/)
- [Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia](https://scholariq.org/papers/suggested-objective-performance-goals-and-clinical-trial-design-for-evaluating/)
- [The natural history of untreated severe or critical limb ischemia](https://scholariq.org/papers/the-natural-history-of-untreated-severe-or-critical-limb-ischemia/)
- [Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial](https://scholariq.org/papers/ex-vivo-gene-therapy-of-human-vascular-bypass-grafts-with-e2f-decoy-the-prevent/)
- [Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST‐CLI) Trial](https://scholariq.org/papers/design-and-rationale-of-the-best-endovascular-versus-best-surgical-therapy-for/)
- [The impact of diabetes mellitus on the outcomes of revascularization for chronic limb-threatening ischemia in the BEST-CLI trial](https://scholariq.org/papers/the-impact-of-diabetes-mellitus-on-the-outcomes-of-revascularization-for-chronic/)

## Researcher topics

- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)
- [Aortic aneurysm repair treatments](https://scholariq.org/topics/aortic-aneurysm-repair-treatments/)
- [Vascular Procedures and Complications](https://scholariq.org/topics/vascular-procedures-and-complications/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)

## Researcher university

- [University of California, San Francisco](https://scholariq.org/institutions/university-of-california-san-francisco/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.